Company / Free Cash Flow per Share
Myriad Genetics, Inc. Free Cash Flow per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.06
FY2022
5-year range
-$2.06 / $0.01
FY2018-FY2022
Trend
-24369.8%
vs FY2021
Sector context
#136 of 192
Health Care
What the data says
Free Cash Flow per Share changed -24370% YoY in FY2022, a notable deviation from the 6-year average annual change of -4090%.
Based on SEC 10-K filings.
-2.06 in FY2022.
Declined from $0.74 to $-2.06 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#136 of 192 in Health CareTop 71% of 192This company -$2.06 Sector average $3.32
▼
-162.2% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s free cash flow per share has declined for 4 consecutive years.
- In FY2022, free cash flow per share decreased 24369.8% year-over-year.
- Ranks #136 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$2.06 | -24369.8% |
| FY2021 | $0.01 | -98.8% |
| FY2020 | $0.74 | -49.0% |
| FY2019 | $1.45 | -7.2% |
| FY2018 | $1.56 | +14.6% |
| FY2017 | $1.36 | -31.9% |
| FY2016 | $2.00 | +41.8% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026